When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PRVB - Provention Bio launches rolling U.S. application for teplizumab
Provention Bio Inc.
Provention Bio (NASDAQ:PRVB) has initiated the rolling submission of its Biologic License Application (BLA) to the FDA for teplizumab (PRV-031), an anti-CD3 monoclonal antibody for the delay or prevention of Type 1 Diabetes (T1D) in at-risk individuals.
More news on: Provention Bio, Inc., Healthcare stocks news,